Preparation and Characterization of Gentiopicroside Nano-lipid Carriers
LI Yong-ji
Abstract
LI Yong-ji
Abstract
Objective: To prepare gentiopicroside nano-lipid carriers(GEN-NLC) and investigate its stability,in vitro release and properties.Method: Solvent dispersion method was used to prepare GEN-NLC.With particle size,Zeta potential and encapsulation efficiency as indexes,effects of proportion of solid-liquid lipid,drug-lipid ratio and the type and concentration of surfactant on preparation technology were investigated,morphology of prepared GEN-NLC was observed by transmission electron microscopy,its characteristics and stability was investigated.Result: Optimal prescription was as following: 0.1% poloxamer 188 as surfactant,drug-lipid ratio 1 ∶ 10,liquid lipid ratio 10%.Encapsulation efficiency of prepared GEN-NLC was(38.19 ± 1.61) %,drug loading was(3.47 ± 0.08) %,particle size was(129.9 ± 3.07) nm,PDI was(0.264 ± 0.01),Zeta potential was(-22.5 ± 0.42) mV.GEN-NLC was spherical particles and showed monodisperse distribution,rounded appearance and uniform size.After stored at 4 ℃ for 30 d,indicators were not changed significantly,release of gentiopicroside 39.65% in 4 h,cumulative release amounted to 79.86% at 36 h.Conclusion: It showed that there were good physicochemical properties and stability of GEN-NLC prepared by solvent dispersion method,and had a certain degree of sustained-release long-lasting effect.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To prepare gentiopicroside nano-lipid carriers(GEN-NLC) and investigate its stability,in vitro release and properties.Method: Solvent dispersion method was used to prepare GEN-NLC.With particle size,Zeta potential and encapsulation efficiency as indexes,effects of proportion of solid-liquid lipid,drug-lipid ratio and the type and concentration of surfactant on preparation technology were investigated,morphology of prepared GEN-NLC was observed by transmission electron microscopy,its characteristics and stability was investigated.Result: Optimal prescription was as following: 0.1% poloxamer 188 as surfactant,drug-lipid ratio 1 ∶ 10,liquid lipid ratio 10%.Encapsulation efficiency of prepared GEN-NLC was(38.19 ± 1.61) %,drug loading was(3.47 ± 0.08) %,particle size was(129.9 ± 3.07) nm,PDI was(0.264 ± 0.01),Zeta potential was(-22.5 ± 0.42) mV.GEN-NLC was spherical particles and showed monodisperse distribution,rounded appearance and uniform size.After stored at 4 ℃ for 30 d,indicators were not changed significantly,release of gentiopicroside 39.65% in 4 h,cumulative release amounted to 79.86% at 36 h.Conclusion: It showed that there were good physicochemical properties and stability of GEN-NLC prepared by solvent dispersion method,and had a certain degree of sustained-release long-lasting effect.
Key concepts: Dispersity, Pulmonary surfactant, Zeta potential, Particle size, Poloxamer, Chromatography, Solvent, Chemistry